“CD44 silencing decreases the expression of stem cell-related factors induced by transforming growth factor β1 and tumor necrosis factor α in lung cancer: Preliminary findings” (2017) Biomolecules and Biomedicine, 17(3), pp. 228–234. doi:10.17305/bjbms.2017.1966.